LM
Tulane University
An adjuvant that brings subunit immunogens up to the protection of conventional avian bronchitis vaccines.
Co-developmentIn-development
Get the Discover digest
Receive a weekly email digest of the latest vaccine development solutions added by the network.Discover innovations in vaccine development
Get the Discover digest
Receive a weekly email digest of the latest vaccine development solutions added by the network.Browse 325 solutions in vaccine development on the Halo network
Updated Nov 2, 2026
Vaccine development covers antigens, adjuvants, delivery formats and the manufacturing needed to make a dose repeatably. On Halo, the solutions cover poultry vaccines, companion animal and livestock vaccines, mucosal and vectored platforms, and delivery systems and adjuvants. Sign up to search the full network and post your specific need.
Poultry vaccines
LM
SH
Molecular Express, Inc. · Supplier
A liposomal subunit vaccine against avian infectious bronchitis virus.
In-development
JL
POP Biotechnologies · Startup
Liposome-displayed H5 antigen built with SNAP chemistry for highly pathogenic avian influenza.
Co-developmentIn-development
Companion animal and livestock vaccines
JD
Consulting-ai · Startup
A second-generation modified-live Leptospira vaccine for dogs, built with CRISPR-made deletions.
Sponsored researchIn-development
IA
University of Crete
A personalized implantable vaccine on a laser-modified silicon scaffold, for feline virus.
Sponsored researchEarly-stage
SP
Texas A&M University, College Station
A reproducible dry cow mastitis challenge model, so a vaccine candidate can be tested against real pathogens.
In-development
Mucosal and vectored platforms
WM
Kansas State University
An attenuated bovine parainfluenza vector giving mucosal and systemic protection against H5N1.
LicensingIn-development
WM
Kansas State University
The same vector used for a broadly protective mucosal Ebola vaccine.
LicensingIn-development
SR
North Dakota State University (NDSU)
A patented method for standing up a vaccine quickly against a new threat.
Sponsored researchIn-development
Delivery systems and adjuvants
YW
Binghamton University
PEG-free biodegradable mRNA lipid nanoparticles built from lipidated proteins.
In-development
RL
Vesimmune · Startup
Extracellular vesicles loaded by tryptophan-activated budding, carrying antigen naturally.
Sponsored researchIn-development
Manufacturing and stabilization
JE
Cyternity Inc · Startup
Dry ambient storage of proteins, RNA, DNA and living cells, cutting cold-chain cost in manufacture and distribution.
LicensingIn-development
You're viewing a preview of vaccine development solutions on Halo.
Sign up free to search the full network and post your specific need.
Already have an account?
Who is working on vaccine development
Organizations in vaccine development
Universities, startups, and suppliers with solutions in vaccine development.
Vaccine development organizations
Innovators in vaccine development
Researchers and inventors advancing vaccine development.
Vaccine development expertsAbout vaccine development
Vaccine development on Halo is mostly veterinary. Poultry and companion animal programs outnumber human ones, and much of the platform work is about the route a dose takes and not the antigen it carries. On Halo it spans five groups, including poultry vaccines, companion animal and livestock vaccines, and mucosal and vectored platforms.
Stage of development. Work on vaccine development on Halo is split between university programs and companies. 83% are past proof of concept (TRL 4 or higher). Co-development and sponsored research are the usual partnering routes, and about 29% of the solutions that state terms offer pilot engagements.
Three trends in vaccine development on Halo
Poultry first. Avian infectious bronchitis alone accounts for four different platforms, an adjuvanted subunit, a liposomal subunit, a DNA origami nanoparticle and a modular system meant to be re-pointed as variants emerge. Commercial pressure in poultry is pulling vaccine formats forward faster than human indications on the page.
The route as the product. Several solutions are about how a dose gets in and not what it contains: microparticles given by spray, orally or in ovo, a mucosal vector delivering both H5N1 and Ebola antigens, and one-step encapsulation for an adjuvant-free oral antigen. For a flock or a herd, the route decides whether a vaccine is usable at all.
Doses that survive the journey. Stabilization work sits beside the antigens. One platform stabilizes proteins, RNA and DNA broadly enough to cut cold chain cost; another manufactures nanocarriers continuously by jet mixing. Both treat distribution as part of the vaccine and not a problem for afterwards.
313organizations
325solutions listed
56%from university labs
83%past proof of concept
Frequently asked questions
What is vaccine development?
Vaccine development covers the antigens, adjuvants, delivery formats and manufacturing that turn an immune target into a dose that can be given repeatably. It spans viral vectors and subunit designs, lipid nanoparticles and other carriers, adjuvant chemistry, and the stabilization and fill processes that let a dose survive distribution. Human and veterinary vaccine developers do the work.
What are examples of vaccine development?
Five examples of vaccine development solutions on Halo include:
- An adjuvant that brings subunit immunogens up to the protection of conventional avian bronchitis vaccines. (Tulane University)
- A second-generation modified-live Leptospira vaccine for dogs, built with CRISPR-made deletions. (Consulting-ai)
- An attenuated bovine parainfluenza vector giving mucosal and systemic protection against H5N1. (Kansas State University)
- PEG-free biodegradable mRNA lipid nanoparticles built from lipidated proteins. (Binghamton University)
- Dry ambient storage of proteins, RNA, DNA and living cells, cutting cold-chain cost in manufacture and distribution. (Cyternity Inc)
What are the latest vaccine development innovations?
The most recently updated vaccine development solutions on Halo include:
Which companies and suppliers are developing vaccine development?
There are 313 organizations with vaccine development solutions on Halo, 76 of them universities and research institutions. Among them are Tulane University, Molecular Express, Inc., and POP Biotechnologies. Most offer co-development or sponsored research. Sign up to see every organization working in the area and to send them your specific need.
How do I find vaccine development research partners?
Browsing vaccine development solutions on Halo is free. Sign up to search the full network and save the ones you want. Post your specific need to get exact matches. Organizations reply directly on the platform.
What are R&D teams looking for in vaccine development?
Over the past 12 months, R&D teams on Halo have posted these vaccine development needs:
Related medicine research areas
Confirm digest type